Hematology/Oncology News

The FDA approved two oncology regimens on Jan. 16.

CMS has selected 15 new drugs for the next round of Medicare Part D price negotiations, according to a press release from HHS.

Lee Greenberger, PhD, has retired as The Leukemia & Lymphoma Society’s chief scientific officer after more than a decade in the position.

Breast cancer survivors who harbor BRCA gene mutation are at elevated risk for second primary cancers, according to study results.

Latinas in the U.S. medical system experience disproportionate barriers and discriminatory behaviors from colleagues and patients, according to results of an online survey.

Cancer incidence has continued to rise in the U.S. since the 1990s — particularly among women and younger adults, according to an American Cancer Society report.

Adjuvant ado-trastuzumab emtansine significantly prolonged survival compared with trastuzumab for certain women with HER2-positive breast cancer, according to long-term results of a randomized phase 3 trial.

The FDA announced a ban on the controversial red dye no. 3, which gives food and drinks a bright, cherry red color and has also been associated with cancer in laboratory rats.

The FDA has proposed limiting the level of nicotine in cigarettes and other combusted tobacco products like cigars and pipe tobacco to make them “minimally or nonaddictive,” according to a press release from the agency.